Register entry

Orexo US, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
6
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

6

6 active NDC listings: 6 human prescription drug. By marketing category: NDA 6.

Dosage formNDCs
tablet, orally disintegrating6
RouteNDCs
sublingual6
Labeller name on the listingNDCs
orexo us, inc.6
Catalogue

Marketed products

6
BrandGeneric nameForm / routeNDC
Zubsolvbuprenorphine hydrochloride and naloxone hydrochloridetablet, orally disintegrating, sublingual54123-114NDA
Zubsolvbuprenorphine hydrochloride and naloxone hydrochloridetablet, orally disintegrating, sublingual54123-907NDA
Zubsolvbuprenorphine hydrochloride and naloxone hydrochloridetablet, orally disintegrating, sublingual54123-914NDA
Zubsolvbuprenorphine hydrochloride and naloxone hydrochloridetablet, orally disintegrating, sublingual54123-929NDA
Zubsolvbuprenorphine hydrochloride and naloxone hydrochloridetablet, orally disintegrating, sublingual54123-957NDA
Zubsolvbuprenorphine hydrochloride and naloxone hydrochloridetablet, orally disintegrating, sublingual54123-986NDA
Compare

Other companies listing buprenorphine hydrochloride and naloxone hydrochloride

Enquiry

Common questions

Is Orexo US, Inc. FDA approved?
Orexo US, Inc. holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Orexo US, Inc. make?
6 products are listed under Orexo US, Inc. in the openFDA NDC Directory, most often as tablet, orally disintegrating. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.